'Brca' presentation slideshows

The Role of PARP inhibitors in Breast Cancer

The Role of PARP inhibitors in Breast Cancer. QROC November 5 th , 2010 Rebecca Dent, MD FRCP(C) Sunnybrook Odette Cancer Center Toronto, Canada. Potential Conflict of Interest. Dr. Rebecca Dent AstraZeneca, consultant and honorariat (2007-2010)

922 views • 49 slides

Perspectives on PARP Inhibitors in Ovarian Cancer Has the Time Come for Individualized Care?

Perspectives on PARP Inhibitors in Ovarian Cancer Has the Time Come for Individualized Care?. Activity Goals. Epidemiology: Ovarian Cancer. PARP and DNA Repair. BRCA and DNA Repair. Synthetic Lethality Is Associated With Inhibition of PARP in the Presence of BRCA Deficiency.

720 views • 38 slides

Considerations for Analyzing Targeted NGS Data BRCA

Considerations for Analyzing Targeted NGS Data BRCA. Omixon Workshops. Considerations for Analyzing Targeted NGS Data - BRCA. Tim Hague, CEO. Tim Hague , CTO. Introduction. BRCA 1 and 2 are best known as 'cancer susceptibility' genes Actually the proteins repair damage in DNA

436 views • 30 slides

BRCA Genes

BRCA Genes. Dallas Henson. BR east CA ncer. Women have about a 1 in 7 chance of getting breast cancer in their lifetime. Most cancer is sporadic, about 5-10% of cases are genetically linked Women inheriting mutation of BRCA gene have increased chance of disease

723 views • 24 slides

Genetics and Breast and Ovarian Cancer

Genetics and Breast and Ovarian Cancer. An Introduction. Genetics and Breast Cancer. Inherited breast/ovarian cancer is an autosomal dominant condition Occurs as a result of mutations in BRCA1 or BRCA2 genes BRCA 1 - gene on chromosome 17 BRCA 2 - gene on chromosome 13.

432 views • 13 slides

Absite Topic Review General Surgery

542 views • 7 slides